These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 5745527)

  • 1. [Fibrinolytic properties of the wall of the aorta in man].
    Andreenko GV; Nikitin IuP; Tabarovskaia TA
    Dokl Akad Nauk SSSR; 1968 Sep; 182(2):469-70. PubMed ID: 5745527
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fibrinolytic activity of urine in proteinuria].
    Lausch A; Thiele G
    Z Gesamte Inn Med; 1971 Oct; 26(20):662-4. PubMed ID: 5211691
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood clotting and fibrinolytic studies in patients with muscular dystrophy.
    Bond TP; Guest MM
    Tex Rep Biol Med; 1964 Dec; 22():Suppl 1:886-9. PubMed ID: 5830976
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ulcers and some other morbid syndromes and fibrinolytic activity of the blood. Antifibrinolytic properties of an anti-ulcer concentrate of the vegetable "U" factor].
    Janda R; Cencora A; Uzieblo W
    Przegl Lek; 1969; 25(5):416-21. PubMed ID: 5793553
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thrombolytic therapy].
    Schmutzler R; Koller F
    Ergeb Inn Med Kinderheilkd; 1965; 22():157-210. PubMed ID: 5889464
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on fibrinolytic enzymes in the field of obstetrics and gynecology, especially on tissue activator. II. Localization of tissue activator in the uterus.
    Mori N; Takemoto J
    Acta Obstet Gynaecol Jpn; 1969 Apr; 16(2):92-6. PubMed ID: 5819403
    [No Abstract]   [Full Text] [Related]  

  • 7. [Modification of the euglobulin method of determining the fibrinolytic properties of tissues].
    Golyshenkov SP; Skipetrov VP; Sokratov NV; Ruseĭkin NS
    Lab Delo; 1982; (6):31-3. PubMed ID: 6180230
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the use of antifibrinolytic agents in urology].
    Rosdy E; Biró J; Szendröi Z; Szabó V
    Acta Chir Acad Sci Hung; 1969; 10(1):25-35. PubMed ID: 5800598
    [No Abstract]   [Full Text] [Related]  

  • 9. [Factors of the fibrinolysis of the vascular wall in patients with different severity of atherosclerosis and of different age].
    Kovalenko AN
    Biull Eksp Biol Med; 1982 Jan; 93(1):26-8. PubMed ID: 7199953
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fibrinolytic activity of the human brain and the cerebrospinal fluid].
    Fiori M
    Arch Sci Med (Torino); 1980; 137(2):193-6. PubMed ID: 7224839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A possible explanation of mechanisms inducing inhibition of vascularization of tumours by antifibrinolytic drugs--the influence of migratory behaviour of endothelial cells.
    Teuscher E; Pester E
    Biomed Biochim Acta; 1984; 43(4):447-56. PubMed ID: 6207812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease.
    Günther A; Mosavi P; Ruppert C; Heinemann S; Temmesfeld B; Velcovsky HG; Morr H; Grimminger F; Walmrath D; Seeger W
    Thromb Haemost; 2000 Jun; 83(6):853-60. PubMed ID: 10896238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue factors modifying the spread of periodontal inflammation: a perspective.
    Ruben MP; Cooper SI
    Compend Contin Educ Dent (Lawrenceville); 1981; 2(6):387-92. PubMed ID: 6978232
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rapid measurement of fibrinolytic activity in CSF by t-AMCA score method. Correlation with concentration of antifibrinolytic agent in CSF (author's transl)].
    Nishimatsu T; Shibasaki T; Sasaki H; Nukui H; Kawafuchi J; Okada K
    Rinsho Byori; 1980 Mar; 28(3):265-70. PubMed ID: 7373890
    [No Abstract]   [Full Text] [Related]  

  • 15. [Urinary-plasmin alpha 2 plasmin inhibitor complex (PIC) in patients with diabetic nephropathy].
    Saigo K; Ryo R; Yamaguchi N
    Rinsho Byori; 1993 Jul; 41(7):785-8. PubMed ID: 8361049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial dispersion of foam cells in the human thoracic aorta.
    Tracy RE; Kissling GE; Devaney KO; Lopez CR; Toca VT; Gandia M
    Lab Invest; 1983 Dec; 49(6):693-701. PubMed ID: 6656201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN; Kizim AI
    Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of an acute coronary syndrome in a patient with severe haemophilia A.
    Ferrario C; Renders F; Cairoli A; Vuffray A; Spertini O; Angelillo-Scherrer A
    Haemophilia; 2007 Nov; 13(6):763-5. PubMed ID: 17973854
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cerebral infarction associated with mobile thoracic ascending aortic thrombus in a patient with essential thrombocythemia].
    Hino H; Terasaki T; Hashimoto Y; Hara Y; Uchino M
    Rinsho Shinkeigaku; 1999 Jul; 39(7):705-10. PubMed ID: 10548906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal fibrin clot architecture in nephrotic patients is related to hypofibrinolysis: influence of plasma biochemical modifications: a possible mechanism for the high thrombotic tendency?
    Colle JP; Mishal Z; Lesty C; Mirshahi M; Peyne J; Baumelou A; Bensman A; Soria J; Soria C
    Thromb Haemost; 1999 Nov; 82(5):1482-9. PubMed ID: 10595642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.